BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12742423)

  • 1. Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors: long-term monitoring in stable lung recipients with and without cystic fibrosis.
    Gerbase MW; Fathi M; Spiliopoulos A; Rochat T; Nicod LP
    J Heart Lung Transplant; 2003 May; 22(5):587-90. PubMed ID: 12742423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
    Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
    Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
    Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
    J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.
    Filler G; Zimmering M; Mai I
    Pediatr Nephrol; 2000 Feb; 14(2):100-4. PubMed ID: 10684356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolic acid pharmacokinetics in lung transplant recipients with cystic fibrosis.
    Stuckey L; Clark Ojo T; Park JM; Annesley T; Bartos C; Cibrik DM
    Ther Drug Monit; 2014 Apr; 36(2):148-51. PubMed ID: 24232127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
    Dipchand AI; Pietra B; McCrindle BW; Rosebrook-Bicknell HL; Boucek MM
    J Heart Lung Transplant; 2001 Oct; 20(10):1035-43. PubMed ID: 11595558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A.
    Glanemann M; Klupp J; Langrehr JM; Schröer G; Platz KP; Stange B; Settmacher U; Bechstein WO; Neuhaus P
    Transplant Proc; 2000 May; 32(3):522-3. PubMed ID: 10812095
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of MFF in combinations with tacrolimus and cyclosporine. Findings of C0 and AUC.
    Radzevičienė A; Stankevičius E; Saint-Marcoux F; Marquet P; Maslauskienë R; Kaduševičius E
    Medicine (Baltimore); 2020 Mar; 99(12):e19441. PubMed ID: 32195940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
    Patel CG; Harmon M; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics.
    Kuriata-Kordek M; Boratynska M; Falkiewicz K; Porazko T; Urbaniak J; Wozniak M; Patrzalek D; Szyber P; Klinger M
    Transplant Proc; 2003 Sep; 35(6):2369-71. PubMed ID: 14529944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation.
    Miyazaki T; Tagawa T; Yamasaki N; Tsuchiya T; Matsumoto K; Nagayasu T
    Transplant Proc; 2013; 45(1):356-9. PubMed ID: 23375323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive regimen in lung transplantation: initial intravenous mycophenolate mofetil and cyclosporine avoid cytolytic induction and allow for rapid steroid tapering.
    Fieguth HG; Simon A; Scherer M; Klesius AA; Wiedenmann DE
    Transplant Proc; 2002 Aug; 34(5):1879-80. PubMed ID: 12176611
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.
    Kovarik JM; Curtis JJ; Hricik DE; Pescovitz MD; Scantlebury V; Vasquez A
    Transplant Proc; 2006 Dec; 38(10):3456-8. PubMed ID: 17175302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil pharmacokinetics in transplant patients receiving cyclosporine or tacrolimus in combination therapy.
    Vidal E; Cantarell C; Capdevila L; Monforte V; Roman A; Pou L
    Pharmacol Toxicol; 2000 Oct; 87(4):182-4. PubMed ID: 11097273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
    Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.
    Filler G; Foster J; Berard R; Mai I; Lepage N
    Transplant Proc; 2004 Jun; 36(5):1327-31. PubMed ID: 15251324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.
    Walker S; Habib S; Rose M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1519-20. PubMed ID: 9636618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.